103903,0,Admission,O
103903,0,Date,O
103903,0,:,O
103903,0,[,O
103903,0,*,O
103903,0,*,O
103903,0,2163-6-6,O
103903,0,*,O
103903,0,*,O
103903,0,],O
103903,0,Discharge,O
103903,0,Date,O
103903,0,:,O
103903,0,[,O
103903,0,*,O
103903,0,*,O
103903,0,2163-6-14,O
103903,0,*,O
103903,0,*,O
103903,0,],O
103903,0,Service,O
103903,0,:,O
103903,0,MEDICINE,O
103903,0,Allergies,O
103903,0,:,O
103903,0,Patient,O
103903,0,recorded,O
103903,0,as,O
103903,0,having,O
103903,0,No,O
103903,0,Known,O
103903,0,Allergies,O
103903,0,to,O
103903,0,Drugs,O
103903,0,Attending,O
103903,0,:,O
103903,0,[,O
103903,0,*,O
103903,0,*,O
103903,0,First,O
103903,0,Name3,O
103903,0,(,O
103903,0,LF,O
103903,0,),O
103903,0,689,O
103903,0,*,O
103903,0,*,O
103903,0,],O
103903,0,Chief,O
103903,0,Complaint,O
103903,0,:,O
103903,0,invasive,O
103903,0,sqamous,O
103903,0,scalp,O
103903,0,ca,O
103903,0,Major,O
103903,0,Surgical,O
103903,0,or,O
103903,0,Invasive,O
103903,0,Procedure,O
103903,0,:,O
103903,0,PICC,O
103903,0,line,O
103903,0,placement,O
103903,0,",",O
103903,0,neurosurgical,O
103903,0,intervention,O
103903,0,cancelled,O
103903,0,",",O
103903,0,History,O
103903,0,of,O
103903,0,Present,O
103903,0,Illness,O
103903,0,:,O
103903,0,Patient,O
103903,0,is,O
103903,0,a,O
103903,0,[,O
103903,0,*,O
103903,0,*,O
103903,0,Age,O
103903,0,over,O
103903,0,90,O
103903,0,*,O
103903,0,*,O
103903,0,],O
103903,0,year,O
103903,0,old,O
103903,0,female,O
103903,0,with,O
103903,0,afib,O
103903,0,",",O
103903,0,cad,O
103903,0,",",O
103903,0,dm,O
103903,0,who,O
103903,0,was,O
103903,0,transferred,O
103903,0,from,O
103903,0,[,O
103903,1,*,O
103903,1,*,O
103903,1,Hospital1,O
103903,1,*,O
103903,1,*,O
103903,1,],O
103903,1,[,O
103903,1,*,O
103903,1,*,O
103903,1,Hospital1,O
103903,1,*,O
103903,1,*,O
103903,1,],O
103903,1,for,O
103903,1,lesion,O
103903,1,on,O
103903,1,scalp,O
103903,1,(,O
103903,1,can,O
103903,1,see,O
103903,1,brain,O
103903,1,matter,O
103903,1,),O
103903,1,.,O
103903,1,She,O
103903,1,was,O
103903,1,evaluated,O
103903,1,as,O
103903,1,an,O
103903,1,outpatient,O
103903,1,intially,O
103903,1,by,O
103903,1,dermatology,O
103903,1,that,O
103903,1,did,O
103903,1,a,O
103903,1,biopsy,O
103903,1,of,O
103903,1,the,O
103903,1,scalp,O
103903,1,mass,O
103903,1,and,O
103903,1,she,O
103903,1,was,O
103903,1,diagnosed,O
103903,1,with,O
103903,1,squamous,O
103903,1,cell,O
103903,1,carcinoma,O
103903,1,.,O
103903,1,The,O
103903,1,ulcerative,O
103903,1,lesion,O
103903,1,eroding,O
103903,1,skull,O
103903,1,extending,O
103903,1,intracranially,O
103903,1,and,O
103903,1,was,O
103903,1,to,O
103903,1,have,O
103903,1,neurosurgical,O
103903,1,intervention,O
103903,1,but,O
103903,1,the,O
103903,1,patient,O
103903,1,was,O
103903,1,supertheraputic,B-Reason
103903,1,INR,I-Reason
103903,1,of,I-Reason
103903,1,7.7,I-Reason
103903,1,so,O
103903,1,she,O
103903,1,was,O
103903,1,sent,O
103903,1,to,O
103903,1,the,O
103903,1,MICU,O
103903,1,.,O
103903,2,She,O
103903,2,was,O
103903,2,reversed,O
103903,2,with,O
103903,2,reversed,O
103903,2,with,O
103903,2,10,O
103903,2,IV,O
103903,2,K,B-Drug
103903,2,",",O
103903,2,2u,O
103903,2,FFP,B-Drug
103903,2,.,O
103903,2,She,O
103903,2,was,O
103903,2,also,O
103903,2,noted,O
103903,2,to,O
103903,2,have,O
103903,2,arf,O
103903,2,with,O
103903,2,cr,O
103903,2,of,O
103903,2,2,O
103903,2,",",O
103903,2,anuric,O
103903,2,",",O
103903,2,dry,B-Reason
103903,2,on,I-Reason
103903,2,exam,I-Reason
103903,2,with,I-Reason
103903,2,a,I-Reason
103903,2,sodium,I-Reason
103903,2,158,I-Reason
103903,2,--,I-Reason
103903,2,>,I-Reason
103903,2,161,I-Reason
103903,2,.,O
103903,2,She,O
103903,2,received,O
103903,2,a,O
103903,2,NS,B-Drug
103903,2,bolus,O
103903,2,and,O
103903,2,then,O
103903,2,D5W,B-Drug
103903,2,and,O
103903,2,avoiding,O
103903,2,lasix,B-Drug
103903,2,and,O
103903,2,acei,B-Drug
103903,2,given,O
103903,2,renal,O
103903,2,failure,O
103903,2,",",O
103903,2,renal,O
103903,2,ultrasound,O
103903,2,with,O
103903,2,R,O
103903,2,hydro,O
103903,2,and,O
103903,2,pelvic,O
103903,2,mass,O
103903,2,(,O
103903,2,family,O
103903,2,does,O
103903,2,not,O
103903,2,want,O
103903,2,w/u,O
103903,2,),O
103903,2,.,O
103903,2,Patient,O
103903,2,was,O
103903,2,placed,O
103903,2,on,O
103903,2,vanc,B-Drug
103903,2,and,O
103903,2,cetriaxone,B-Drug
103903,2,for,O
103903,2,meningitis,B-Reason
103903,2,proprolaxis,I-Reason
103903,2,since,O
103903,2,there,O
103903,2,is,O
103903,2,CSF,O
103903,2,communicating,O
103903,2,with,O
103903,2,skin,O
103903,2,secondary,O
103903,2,to,O
103903,2,scc,O
103903,2,.,O
103903,3,Patient,O
103903,3,is,O
103903,3,having,O
103903,3,PICC,O
103903,3,placed,O
103903,3,in,O
103903,3,the,O
103903,3,AM,O
103903,3,for,O
103903,3,long-term,O
103903,3,abx,O
103903,3,and,O
103903,3,fluids,B-Drug
103903,3,.,O
103903,3,Cultures,O
103903,3,are,O
103903,3,pending,O
103903,3,.,O
103903,3,Family,O
103903,3,is,O
103903,3,aware,O
103903,3,of,O
103903,3,poor,O
103903,3,prognosis,O
103903,3,and,O
103903,3,she,O
103903,3,is,O
103903,3,dnr/dni,O
103903,3,",",O
103903,3,family,O
103903,3,wants,O
103903,3,conservative,O
103903,3,med,O
103903,3,management,O
103903,3,.,O
103903,3,Past,O
103903,3,Medical,O
103903,3,History,O
103903,3,:,O
103903,3,CHF-unknown,O
103903,3,type,O
103903,3,or,O
103903,3,EF,O
103903,3,.,O
103903,3,bradycardia,O
103903,3,s/p,O
103903,3,pacemaker,O
103903,3,afib-s/p,O
103903,3,cardioversion,O
103903,3,at,O
103903,3,[,O
103903,3,*,O
103903,3,*,O
103903,3,Hospital1,O
103903,3,112,O
103903,3,*,O
103903,3,*,O
103903,3,],O
103903,3,htn,O
103903,3,hyperthyroidism,O
103903,3,arthritis,O
103903,3,hernia,O
103903,3,repair,O
103903,3,anxiety,O
103903,3,h.o,O
103903,3,SCC,O
103903,3,of,O
103903,3,the,O
103903,3,scalp,O
103903,3,year,O
103903,3,ago,O
103903,3,per,O
103903,3,records,O
103903,3,glaucoma,O
103903,3,Social,O
103903,3,History,O
103903,3,:,O
103903,3,Lives,O
103903,3,in,O
103903,3,[,O
103903,3,*,O
103903,3,*,O
103903,3,Location,O
103903,3,*,O
103903,3,*,O
103903,3,],O
103903,3,.,O
103903,4,No,O
103903,4,tobacco,O
103903,4,",",O
103903,4,EtOH,O
103903,4,",",O
103903,4,or,O
103903,4,illicit,O
103903,4,drug,O
103903,4,use,O
103903,4,.,O
103903,4,Family,O
103903,4,History,O
103903,4,:,O
103903,4,Non-contributory,O
103903,4,Physical,O
103903,4,Exam,O
103903,4,:,O
103903,4,Vitals,O
103903,4,:,O
103903,4,T,O
103903,4,98.9,O
103903,4,",",O
103903,4,102/666,O
103903,4,",",O
103903,4,64,O
103903,4,",",O
103903,4,22,O
103903,4,",",O
103903,4,98,O
103903,4,%,O
103903,4,RA,O
103903,4,",",O
103903,4,FS140,O
103903,4,General,O
103903,4,:,O
103903,4,Alert,O
103903,4,",",O
103903,4,trembling,O
103903,4,",",O
103903,4,cooperative,O
103903,4,HEENT,O
103903,4,:,O
103903,4,PERRLA,O
103903,4,",",O
103903,4,3x3cm,O
103903,4,irregular,O
103903,4,discolored,O
103903,4,raised,O
103903,4,mass,O
103903,4,",",O
103903,4,EOMI,O
103903,4,",",O
103903,4,anicteric,O
103903,4,",",O
103903,4,MMM,O
103903,4,neck-JVD,O
103903,4,to,O
103903,4,ear,O
103903,4,?,O
103903,4,positional,O
103903,4,",",O
103903,4,no,O
103903,4,LAD,O
103903,4,chest-b/l,O
103903,4,ae,O
103903,4,no,O
103903,4,w/c/r,O
103903,4,heart-s1s2,O
103903,4,4/6,O
103903,4,systolic,O
103903,4,murmur,O
103903,4,heard,O
103903,4,throughout,O
103903,4,precordium,O
103903,4,abd-+bs,O
103903,4,",",O
103903,4,soft,O
103903,4,",",O
103903,4,Nt,O
103903,4,",",O
103903,4,ND,O
103903,4,ext-NO,O
103903,4,c/c/e,O
103903,4,1+,O
103903,4,puluses,O
103903,4,",",O
103903,4,cold,O
103903,4,",",O
103903,4,r,O
103903,4,first,O
103903,4,toe,O
103903,4,ichemic,O
103903,4,ulcer,O
103903,4,neuro-aaox2,O
103903,4,",",O
103903,4,moves,O
103903,4,all,O
103903,4,extremities,O
103903,4,.,O
103903,5,Pertinent,O
103903,5,Results,O
103903,5,:,O
103903,5,[,O
103903,5,*,O
103903,5,*,O
103903,5,2163-6-6,O
103903,5,*,O
103903,5,*,O
103903,5,],O
103903,5,05:35PM,O
103903,5,PT-63.8,O
103903,5,*,O
103903,5,PTT-41.1,O
103903,5,*,O
103903,5,INR,O
103903,5,(,O
103903,5,PT,O
103903,5,),O
103903,5,-7.7,O
103903,5,*,O
103903,5,[,O
103903,5,*,O
103903,5,*,O
103903,5,2163-6-6,O
103903,5,*,O
103903,5,*,O
103903,5,],O
103903,5,05:35PM,O
103903,5,WBC-13.1,O
103903,5,*,O
103903,5,#,O
103903,5,RBC-3.65,O
103903,5,*,O
103903,5,HGB-10.8,O
103903,5,*,O
103903,5,HCT-35.6,O
103903,5,*,O
103903,5,MCV-98,O
103903,5,MCH-29.7,O
103903,5,#,O
103903,5,MCHC-30.5,O
103903,5,*,O
103903,5,RDW-13.7,O
103903,5,[,O
103903,5,*,O
103903,5,*,O
103903,5,2163-6-6,O
103903,5,*,O
103903,5,*,O
103903,5,],O
103903,5,05:35PM,O
103903,5,cTropnT-0.07,O
103903,5,*,O
103903,5,[,O
103903,5,*,O
103903,5,*,O
103903,5,2163-6-6,O
103903,5,*,O
103903,5,*,O
103903,5,],O
103903,5,05:35PM,O
103903,5,WBC-13.1,O
103903,5,*,O
103903,5,#,O
103903,5,RBC-3.65,O
103903,5,*,O
103903,5,HGB-10.8,O
103903,5,*,O
103903,5,HCT-35.6,O
103903,5,*,O
103903,5,MCV-98,O
103903,5,MCH-29.7,O
103903,5,#,O
103903,5,MCHC-30.5,O
103903,5,*,O
103903,5,RDW-13.7,O
103903,5,[,O
103903,5,*,O
103903,5,*,O
103903,5,2163-6-6,O
103903,5,*,O
103903,5,*,O
103903,5,],O
103903,5,05:35PM,O
103903,5,CK,O
103903,5,(,O
103903,5,CPK,O
103903,5,),O
103903,5,-33,O
103903,5,[,O
103903,5,*,O
103903,5,*,O
103903,5,2163-6-6,O
103903,5,*,O
103903,5,*,O
103903,5,],O
103903,5,05:55PM,O
103903,5,LACTATE-1.7,O
103903,5,CT,O
103903,6,head,O
103903,6,:,O
103903,6,TECHNIQUE,O
103903,6,:,O
103903,6,Axial,O
103903,6,non-contrast,O
103903,6,images,O
103903,6,performed,O
103903,6,in,O
103903,6,an,O
103903,6,outside,O
103903,6,hospital,O
103903,6,(,O
103903,6,[,O
103903,6,*,O
103903,6,*,O
103903,6,Hospital3,O
103903,6,*,O
103903,6,*,O
103903,6,],O
103903,6,),O
103903,6,were,O
103903,6,submitted,O
103903,6,for,O
103903,6,review,O
103903,6,.,O
103903,6,No,O
103903,6,reconstructions,O
103903,6,were,O
103903,6,available,O
103903,6,.,O
103903,6,No,O
103903,6,formal,O
103903,6,report,O
103903,6,was,O
103903,6,provided,O
103903,6,.,O
103903,6,FINDINGS,O
103903,6,:,O
103903,6,Within,O
103903,6,the,O
103903,6,brain,O
103903,6,parenchyma,O
103903,6,",",O
103903,6,there,O
103903,6,is,O
103903,6,global,O
103903,6,parenchymal,O
103903,6,atrophy,O
103903,6,",",O
103903,6,indicated,O
103903,6,by,O
103903,6,enlargement,O
103903,6,of,O
103903,6,the,O
103903,6,ventricles,O
103903,6,and,O
103903,6,sulci,O
103903,6,.,O
103903,6,There,O
103903,6,is,O
103903,6,also,O
103903,6,periventricular,O
103903,6,and,O
103903,6,subcortical,O
103903,6,white,O
103903,6,matter,O
103903,6,hypodensity,O
103903,6,",",O
103903,6,consistent,O
103903,6,with,O
103903,6,small,O
103903,6,vessel,O
103903,6,ischemic,O
103903,6,disease,O
103903,6,.,O
103903,7,A,O
103903,7,right,O
103903,7,cerebellar,O
103903,7,lacunar,O
103903,7,infarct,O
103903,7,is,O
103903,7,also,O
103903,7,noted,O
103903,7,.,O
103903,7,There,O
103903,7,is,O
103903,7,no,O
103903,7,hemorrhage,O
103903,7,",",O
103903,7,edema,O
103903,7,",",O
103903,7,or,O
103903,7,mass,O
103903,7,effect,O
103903,7,.,O
103903,7,There,O
103903,7,is,O
103903,7,no,O
103903,7,shift,O
103903,7,of,O
103903,7,normally,O
103903,7,midline,O
103903,7,structures,O
103903,7,.,O
103903,7,The,O
103903,7,[,O
103903,7,*,O
103903,7,*,O
103903,7,Doctor,O
103903,7,Last,O
103903,7,Name,O
103903,7,352,O
103903,7,*,O
103903,7,*,O
103903,7,],O
103903,7,-white,O
103903,7,matter,O
103903,7,differentiation,O
103903,7,appears,O
103903,7,preserved,O
103903,7,.,O
103903,7,There,O
103903,7,is,O
103903,7,a,O
103903,7,large,O
103903,7,destructive,O
103903,7,lesion,O
103903,7,involving,O
103903,7,the,O
103903,7,vertex,O
103903,7,of,O
103903,7,the,O
103903,7,calvarium,O
103903,7,.,O
103903,7,There,O
103903,7,is,O
103903,7,no,O
103903,7,underlying,O
103903,7,brain,O
103903,7,mass,O
103903,7,lesion,O
103903,7,or,O
103903,7,brain,O
103903,7,abscess,O
103903,7,",",O
103903,7,although,O
103903,7,there,O
103903,7,is,O
103903,7,an,O
103903,7,extra-,O
103903,7,axial,O
103903,7,",",O
103903,7,likely,O
103903,7,subdural,O
103903,7,",",O
103903,7,soft,O
103903,7,tissue/fluid,O
103903,7,component,O
103903,7,to,O
103903,7,this,O
103903,7,lesion,O
103903,7,",",O
103903,7,although,O
103903,7,this,O
103903,7,is,O
103903,7,difficult,O
103903,7,to,O
103903,7,evaluate,O
103903,7,due,O
103903,7,to,O
103903,7,volume,O
103903,7,averaging,O
103903,7,at,O
103903,7,the,O
103903,7,vertex,O
103903,8,and,O
103903,8,the,O
103903,8,lack,O
103903,8,of,O
103903,8,reconstructions,O
103903,8,.,O
103903,8,The,O
103903,8,lesion,O
103903,8,at,O
103903,8,the,O
103903,8,vertex,O
103903,8,causes,O
103903,8,significant,O
103903,8,osseous,O
103903,8,destruction,O
103903,8,.,O
103903,8,There,O
103903,8,is,O
103903,8,subcutaneous,O
103903,8,gas,O
103903,8,",",O
103903,8,which,O
103903,8,also,O
103903,8,extends,O
103903,8,intracranially,O
103903,8,",",O
103903,8,with,O
103903,8,resultant,O
103903,8,pneumocephalus,O
103903,8,.,O
103903,8,IMPRESSION,O
103903,8,:,O
103903,8,1,O
103903,8,.,O
103903,8,Extensive,O
103903,8,destructive,O
103903,8,lesion,O
103903,8,involving,O
103903,8,the,O
103903,8,calvarial,O
103903,8,vertex,O
103903,8,",",O
103903,8,with,O
103903,8,intracranial,O
103903,8,extension,O
103903,8,indicated,O
103903,8,by,O
103903,8,pneumocephalus,O
103903,8,and,O
103903,8,extra-axial,O
103903,8,",",O
103903,8,intracranial,O
103903,8,soft,O
103903,8,tissue/fluid,O
103903,8,component,O
103903,8,.,O
103903,8,This,O
103903,8,does,O
103903,8,not,O
103903,8,appear,O
103903,8,to,O
103903,8,be,O
103903,8,of,O
103903,8,primary,O
103903,8,CNS,O
103903,8,etiology,O
103903,8,.,O
103903,8,Differential,O
103903,8,includes,O
103903,8,infectious,O
103903,8,process,O
103903,8,or,O
103903,8,a,O
103903,8,subcutaneous,O
103903,8,or,O
103903,8,osseous,O
103903,8,malignancy,O
103903,8,.,O
103903,9,Further,O
103903,9,evaluation,O
103903,9,with,O
103903,9,contrast-enhanced,O
103903,9,MRI,O
103903,9,is,O
103903,9,recommended,O
103903,9,.,O
103903,9,2,O
103903,9,.,O
103903,9,Small,O
103903,9,vessel,O
103903,9,ischemic,O
103903,9,disease,O
103903,9,",",O
103903,9,lacunar,O
103903,9,infarcts,O
103903,9,",",O
103903,9,and,O
103903,9,global,O
103903,9,parenchymal,O
103903,9,atrophy,O
103903,9,.,O
103903,9,There,O
103903,9,are,O
103903,9,no,O
103903,9,brain,O
103903,9,mass,O
103903,9,lesions,O
103903,9,or,O
103903,9,brain,O
103903,9,abscesses,O
103903,9,identified,O
103903,9,.,O
103903,9,Renal,O
103903,9,ultrasound,O
103903,9,[,O
103903,9,*,O
103903,9,*,O
103903,9,2163-6-7,O
103903,9,*,O
103903,9,*,O
103903,9,],O
103903,9,:,O
103903,9,FINDINGS,O
103903,9,:,O
103903,9,The,O
103903,9,left,O
103903,9,kidney,O
103903,9,measures,O
103903,9,9,O
103903,9,cm,O
103903,9,in,O
103903,9,length,O
103903,9,.,O
103903,9,There,O
103903,9,is,O
103903,9,no,O
103903,9,left-sided,O
103903,9,hydronephrosis,O
103903,9,.,O
103903,9,The,O
103903,9,right,O
103903,9,kidney,O
103903,9,measures,O
103903,9,9.5,O
103903,9,cm,O
103903,9,in,O
103903,9,length,O
103903,9,.,O
103903,9,There,O
103903,9,is,O
103903,9,moderate,O
103903,9,right-sided,O
103903,9,hydronephrosis,O
103903,9,.,O
103903,10,There,O
103903,10,is,O
103903,10,no,O
103903,10,renal,O
103903,10,mass,O
103903,10,or,O
103903,10,stone,O
103903,10,.,O
103903,10,There,O
103903,10,is,O
103903,10,a,O
103903,10,large,O
103903,10,>,O
103903,10,15,O
103903,10,cm,O
103903,10,cystic,O
103903,10,pelvic,O
103903,10,mass,O
103903,10,",",O
103903,10,which,O
103903,10,can,O
103903,10,not,O
103903,10,be,O
103903,10,further,O
103903,10,characterized,O
103903,10,.,O
103903,10,Bladder,O
103903,10,is,O
103903,10,not,O
103903,10,visualized,O
103903,10,.,O
103903,10,IMPRESSION,O
103903,10,:,O
103903,10,1,O
103903,10,.,O
103903,10,Moderate,O
103903,10,right-sided,O
103903,10,hydronephrosis,O
103903,10,.,O
103903,10,2,O
103903,10,.,O
103903,10,Non-specific,O
103903,10,",",O
103903,10,large,O
103903,10,cystic,O
103903,10,pelvic,O
103903,10,mass,O
103903,10,.,O
103903,10,Brief,O
103903,10,Hospital,O
103903,10,Course,O
103903,10,:,O
103903,10,Patient,O
103903,10,was,O
103903,10,a,O
103903,10,[,O
103903,10,*,O
103903,10,*,O
103903,10,Age,O
103903,10,over,O
103903,10,90,O
103903,10,*,O
103903,10,*,O
103903,10,],O
103903,10,year,O
103903,10,old,O
103903,10,female,O
103903,10,with,O
103903,10,h.o,O
103903,10,CHF,O
103903,10,",",O
103903,10,DM,O
103903,10,",",O
103903,10,afib,O
103903,10,",",O
103903,10,who,O
103903,10,presented,O
103903,10,with,O
103903,10,invasive,O
103903,10,scalp,O
103903,10,squamous,O
103903,10,cell,O
103903,10,carcinoma,O
103903,10,with,O
103903,10,intracranial,O
103903,10,extension,O
103903,10,who,O
103903,10,died,O
103903,10,after,O
103903,10,code,O
103903,10,status,O
103903,10,was,O
103903,10,CMO,O
103903,10,.,O
103903,11,.,O
103903,11,#,O
103903,11,CMO,O
103903,11,-,O
103903,11,Had,O
103903,11,family,O
103903,11,meeting,O
103903,11,[,O
103903,11,*,O
103903,11,*,O
103903,11,6-10,O
103903,11,*,O
103903,11,*,O
103903,11,],O
103903,11,.,O
103903,11,Discussed,O
103903,11,to,O
103903,11,stop,O
103903,11,vital,O
103903,11,signs,O
103903,11,",",O
103903,11,non-essential,O
103903,11,medications,O
103903,11,other,O
103903,11,than,O
103903,11,eye,B-Drug
103903,11,drops,I-Drug
103903,11,",",O
103903,11,pain,B-Drug
103903,11,meds,I-Drug
103903,11,",",O
103903,11,and,O
103903,11,PO,O
103903,11,antibiotics,B-Drug
103903,11,.,O
103903,11,Patient,O
103903,11,was,O
103903,11,continued,O
103903,11,on,O
103903,11,maintainance,O
103903,11,IV,O
103903,11,fluids,B-Drug
103903,11,.,O
103903,11,.,O
103903,11,#,O
103903,11,Pain,B-Reason
103903,11,control,I-Reason
103903,11,-,O
103903,11,This,O
103903,11,was,O
103903,11,the,O
103903,11,family,O
103903,11,'s,O
103903,11,primary,O
103903,11,goal,O
103903,11,of,O
103903,11,care,O
103903,11,.,O
103903,11,There,O
103903,11,were,O
103903,11,multiple,O
103903,11,etiologies,O
103903,11,of,O
103903,11,the,O
103903,11,pain,O
103903,11,including,O
103903,11,her,O
103903,11,chonic,O
103903,11,right,O
103903,11,shoulder,O
103903,11,pain,O
103903,11,",",O
103903,11,sacral,O
103903,11,decubiti,O
103903,11,with,O
103903,11,possible,O
103903,11,abcess,O
103903,11,",",O
103903,11,painful,O
103903,11,scalp,O
103903,11,leison,O
103903,11,",",O
103903,11,or,O
103903,11,the,O
103903,11,>,O
103903,11,15cm,O
103903,11,pelvic,O
103903,11,mass,O
103903,11,.,O
103903,12,Pain,O
103903,12,control,O
103903,12,was,O
103903,12,transitioned,O
103903,12,from,O
103903,12,outpatient,O
103903,12,oxycontin,B-Drug
103903,12,pills,O
103903,12,to,O
103903,12,fenanyl,B-Drug
103903,12,patch,O
103903,12,and,O
103903,12,oxycodone,B-Drug
103903,12,liquid,O
103903,12,.,O
103903,12,Patient,O
103903,12,was,O
103903,12,comfortably,O
103903,12,sedated,O
103903,12,and,O
103903,12,only,O
103903,12,required,O
103903,12,additional,O
103903,12,pain,O
103903,12,medication,O
103903,12,when,O
103903,12,she,O
103903,12,was,O
103903,12,moved,O
103903,12,.,O
103903,12,Palliative,O
103903,12,care,O
103903,12,was,O
103903,12,involved,O
103903,12,in,O
103903,12,pain,O
103903,12,management,O
103903,12,.,O
103903,12,.,O
103903,12,#,O
103903,12,Squamous,O
103903,12,cell,O
103903,12,ca,O
103903,12,",",O
103903,12,intracranial-,O
103903,12,The,O
103903,12,carcinoma,O
103903,12,developed,O
103903,12,over,O
103903,12,an,O
103903,12,unknown,O
103903,12,time,O
103903,12,period,O
103903,12,.,O
103903,12,It,O
103903,12,probably,O
103903,12,developed,O
103903,12,before,O
103903,12,her,O
103903,12,care,O
103903,12,to,O
103903,12,nursing,O
103903,12,home,O
103903,12,facility,O
103903,12,given,O
103903,12,that,O
103903,12,there,O
103903,12,was,O
103903,12,a,O
103903,12,rapid,O
103903,12,decline,O
103903,12,in,O
103903,12,her,O
103903,12,functional,O
103903,12,status,O
103903,12,and,O
103903,12,intracraninal,O
103903,12,involvement,O
103903,12,of,O
103903,12,the,O
103903,12,tumor,O
103903,12,.,O
103903,13,She,O
103903,13,was,O
103903,13,evaluated,O
103903,13,as,O
103903,13,an,O
103903,13,outpatient,O
103903,13,by,O
103903,13,dermatology,O
103903,13,and,O
103903,13,was,O
103903,13,determined,O
103903,13,to,O
103903,13,have,O
103903,13,a,O
103903,13,squamous,O
103903,13,cell,O
103903,13,ca,O
103903,13,as,O
103903,13,per,O
103903,13,biopsy,O
103903,13,on,O
103903,13,[,O
103903,13,*,O
103903,13,*,O
103903,13,5-25,O
103903,13,*,O
103903,13,*,O
103903,13,],O
103903,13,.,O
103903,13,Initially,O
103903,13,",",O
103903,13,the,O
103903,13,family,O
103903,13,wanted,O
103903,13,to,O
103903,13,have,O
103903,13,a,O
103903,13,neurosurgical,O
103903,13,intervention,O
103903,13,",",O
103903,13,but,O
103903,13,the,O
103903,13,patient,O
103903,13,'s,O
103903,13,INR,O
103903,13,was,O
103903,13,7.7,O
103903,13,so,O
103903,13,she,O
103903,13,was,O
103903,13,transferred,O
103903,13,to,O
103903,13,the,O
103903,13,MICU,O
103903,13,for,O
103903,13,reversal,O
103903,13,.,O
103903,13,Later,O
103903,13,",",O
103903,13,the,O
103903,13,family,O
103903,13,decided,O
103903,13,not,O
103903,13,to,O
103903,13,have,O
103903,13,surgery,O
103903,13,once,O
103903,13,it,O
103903,13,became,O
103903,13,apparent,O
103903,13,that,O
103903,13,the,O
103903,13,morbity,O
103903,13,was,O
103903,13,high,O
103903,13,.,O
103903,14,Patient,O
103903,14,was,O
103903,14,started,O
103903,14,on,O
103903,14,vancomycin,B-Drug
103903,14,and,O
103903,14,ceftriaxone,B-Drug
103903,14,for,O
103903,14,meningitis,B-Reason
103903,14,ppx,I-Reason
103903,14,and,O
103903,14,this,O
103903,14,was,O
103903,14,changed,O
103903,14,to,O
103903,14,PO,O
103903,14,cefepoxidime,B-Drug
103903,14,after,O
103903,14,a,O
103903,14,family,O
103903,14,meeting,O
103903,14,determining,O
103903,14,that,O
103903,14,she,O
103903,14,would,O
103903,14,not,O
103903,14,want,O
103903,14,IV,O
103903,14,antibiotics,B-Drug
103903,14,.,O
103903,14,Wound,O
103903,14,care,O
103903,14,was,O
103903,14,done,O
103903,14,to,O
103903,14,address,O
103903,14,her,O
103903,14,head,O
103903,14,wound,O
103903,14,.,O
103903,14,.,O
103903,14,#,O
103903,14,Resolved,O
103903,14,hypovolemia/,O
103903,14,acute,O
103903,14,renal,O
103903,14,failure/,O
103903,14,hypernatremia,O
103903,14,-,O
103903,14,secondary,O
103903,14,to,O
103903,14,dehydration,B-ADE
103903,14,and,O
103903,14,intravascular,B-ADE
103903,14,hypovolemia,I-ADE
103903,14,in,O
103903,14,the,O
103903,14,setting,O
103903,14,of,O
103903,14,diruetic,B-Drug
103903,14,use,O
103903,14,.,O
103903,14,Cr,O
103903,14,2.0,O
103903,14,on,O
103903,14,admission,O
103903,14,",",O
103903,14,most,O
103903,14,recent,O
103903,14,baseline,O
103903,14,at,O
103903,14,[,O
103903,14,*,O
103903,14,*,O
103903,14,Hospital1,O
103903,14,18,O
103903,14,*,O
103903,14,*,O
103903,14,],O
103903,14,1.1,O
103903,14,.,O
103903,15,This,O
103903,15,was,O
103903,15,the,O
103903,15,reason,O
103903,15,for,O
103903,15,the,O
103903,15,PICC,O
103903,15,line,O
103903,15,placement,O
103903,15,and,O
103903,15,why,O
103903,15,the,O
103903,15,family,O
103903,15,wanted,O
103903,15,IVF,B-Drug
103903,15,.,O
103903,15,.,O
103903,15,#,O
103903,15,Pelvic,O
103903,15,mass,O
103903,15,-,O
103903,15,There,O
103903,15,is,O
103903,15,a,O
103903,15,large,O
103903,15,>,O
103903,15,15,O
103903,15,cm,O
103903,15,cystic,O
103903,15,pelvic,O
103903,15,mass,O
103903,15,seen,O
103903,15,on,O
103903,15,renal,O
103903,15,ultrasound,O
103903,15,.,O
103903,15,This,O
103903,15,may,O
103903,15,be,O
103903,15,a,O
103903,15,source,O
103903,15,of,O
103903,15,pain,O
103903,15,.,O
103903,15,.,O
103903,15,#,O
103903,15,afib,O
103903,15,not,O
103903,15,on,O
103903,15,anticoagulation,O
103903,15,-,O
103903,15,Patient,O
103903,15,has,O
103903,15,a,O
103903,15,history,O
103903,15,of,O
103903,15,atrial,O
103903,15,fibrillation,O
103903,15,but,O
103903,15,was,O
103903,15,placed,O
103903,15,on,O
103903,15,anticoagulation,O
103903,15,for,O
103903,15,a,O
103903,15,recent,O
103903,15,phelbiltis,O
103903,15,.,O
103903,15,Given,O
103903,15,that,O
103903,15,the,O
103903,15,scalp,O
103903,15,wound,O
103903,15,oozes,O
103903,15,blood,O
103903,15,",",O
103903,15,the,O
103903,15,family,O
103903,15,has,O
103903,15,decided,O
103903,15,that,O
103903,15,they,O
103903,15,do,O
103903,15,not,O
103903,15,want,O
103903,15,anticoagulation,O
103903,15,.,O
103903,16,.,O
103903,16,#,O
103903,16,DM-HISS,O
103903,16,.,O
103903,16,COMFORT,O
103903,16,MEASURES,O
103903,16,ONLY,O
103903,16,DISCHARGE,O
103903,16,TO,O
103903,16,DEATH,O
103903,16,Medications,O
103903,16,on,O
103903,16,Admission,O
103903,16,:,O
103903,16,Medications,O
103903,16,at,O
103903,16,home,O
103903,16,:,O
103903,16,Lasix,B-Drug
103903,16,40,O
103903,16,mg,O
103903,16,PO,O
103903,16,daily,O
103903,16,Lisinopril,B-Drug
103903,16,40,O
103903,16,mg,O
103903,16,PO,O
103903,16,daily,O
103903,16,OxyContin,B-Drug
103903,16,20,O
103903,16,mg,O
103903,16,PO,O
103903,16,q12,O
103903,16,",",O
103903,16,10mg,O
103903,16,PO,O
103903,16,qHS,O
103903,16,Xalatan,B-Drug
103903,16,0.005,O
103903,16,%,O
103903,16,Eye,O
103903,16,Drops,O
103903,16,1,O
103903,16,Drops,O
103903,16,(,O
103903,16,s,O
103903,16,),O
103903,16,Once,O
103903,16,Daily,O
103903,16,",",O
103903,16,at,O
103903,16,bedtime,O
103903,16,Azopt,B-Drug
103903,16,1,O
103903,16,%,O
103903,16,Eye,O
103903,16,Drops,O
103903,16,Ophthalmic,O
103903,16,1,O
103903,16,drop,O
103903,16,daily,O
103903,16,Tylenol,B-Drug
103903,16,1g,O
103903,16,PO,O
103903,16,TID,O
103903,16,Serax,B-Drug
103903,16,10mg,O
103903,16,PO,O
103903,16,BID,O
103903,16,MVI,B-Drug
103903,16,PO,O
103903,16,daily,O
103903,16,Pro-Stat,B-Drug
103903,16,64,I-Drug
103903,16,--,O
103903,16,Unknown,O
103903,16,Strength,O
103903,16,",",O
103903,16,Twice,O
103903,16,Daily,O
103903,16,Zinc,B-Drug
103903,16,Chelated,O
103903,16,50,O
103903,16,mg,O
103903,16,PO,O
103903,16,daily,O
103903,16,Vitamin,B-Drug
103903,16,C,I-Drug
103903,16,500,O
103903,16,mg,O
103903,16,SR,O
103903,16,PO,O
103903,16,daily,O
103903,16,Simethicone,B-Drug
103903,16,80,O
103903,16,mg,O
103903,16,chewable,O
103903,16,tab,O
103903,16,PO,O
103903,16,prn,O
103903,17,.,O
103903,17,Medications,O
103903,17,on,O
103903,17,transfer,O
103903,17,:,O
103903,17,CeftriaXONE,B-Drug
103903,17,1,O
103903,17,gm,O
103903,17,IV,O
103903,17,Q24H,O
103903,17,Vancomycin,B-Drug
103903,17,1000,O
103903,17,mg,O
103903,17,IV,O
103903,17,ONCE,O
103903,17,(,O
103903,17,dose,O
103903,17,by,O
103903,17,level,O
103903,17,),O
103903,17,Oxycodone,B-Drug
103903,17,SR,I-Drug
103903,17,(,O
103903,17,OxyconTIN,B-Drug
103903,17,),O
103903,17,10,O
103903,17,mg,O
103903,17,PO,O
103903,17,Q12H,O
103903,17,Humalog,B-Drug
103903,17,insulin,I-Drug
103903,17,sliding,O
103903,17,scale,O
103903,17,Latanoprost,B-Drug
103903,17,0.005,O
103903,17,%,O
103903,17,Ophth,O
103903,17,.,O
103903,17,Soln,O
103903,17,.,O
103903,17,1,O
103903,17,DROP,O
103903,17,BOTH,O
103903,17,EYES,O
103903,17,HS,O
103903,17,Pantoprazole,B-Drug
103903,17,40,O
103903,17,mg,O
103903,17,PO,O
103903,17,Q24H,O
103903,17,Docusate,B-Drug
103903,17,Sodium,I-Drug
103903,17,(,O
103903,17,Liquid,O
103903,17,),O
103903,17,100,O
103903,17,mg,O
103903,17,PO,O
103903,17,BID,O
103903,17,Multivitamins,B-Drug
103903,17,1,O
103903,17,TAB,O
103903,17,PO,O
103903,17,DAILY,O
103903,17,Oxazepam,B-Drug
103903,17,10,O
103903,17,mg,O
103903,17,PO,O
103903,17,BID,O
103903,17,:,O
103903,17,PRN,O
103903,17,anxiety,B-Reason
103903,17,Acetaminophen,B-Drug
103903,17,325-650,O
103903,17,mg,O
103903,17,PO,O
103903,17,Q6H,O
103903,17,:,O
103903,17,PRN,O
103903,17,pain,B-Reason
103903,17,/,O
103903,17,fever,B-Reason
103903,17,Bisacodyl,B-Drug
103903,17,10,O
103903,17,mg,O
103903,17,PO/PR,O
103903,17,DAILY,O
103903,17,:,O
103903,17,PRN,O
103903,17,Senna,B-Drug
103903,17,1,O
103903,17,TAB,O
103903,17,PO,O
103903,17,BID,O
103903,17,:,O
103903,17,PRN,O
103903,17,Discharge,O
103903,17,Medications,O
103903,17,:,O
103903,17,NONE,O
103903,18,Discharge,O
103903,18,Disposition,O
103903,18,:,O
103903,18,Expired,O
103903,18,Discharge,O
103903,18,Diagnosis,O
103903,18,:,O
103903,18,Primary,O
103903,18,:,O
103903,18,intracranial,O
103903,18,extension,O
103903,18,of,O
103903,18,invasive,O
103903,18,sqamous,O
103903,18,cell,O
103903,18,carcinoma,O
103903,18,Secondary,O
103903,18,:,O
103903,18,resolved,O
103903,18,acute,O
103903,18,renal,O
103903,18,failure,O
103903,18,secondary,O
103903,18,to,O
103903,18,dehydration,O
103903,18,pelvic,O
103903,18,mass,O
103903,18,of,O
103903,18,unknown,O
103903,18,etiology,O
103903,18,atrial,O
103903,18,fibrillation,O
103903,18,",",O
103903,18,chronic,O
103903,18,hypertension,O
103903,18,diabetes,O
103903,18,mellitus,O
103903,18,",",O
103903,18,type,O
103903,18,2,O
103903,18,Discharge,O
103903,18,Condition,O
103903,18,:,O
103903,18,expired,O
103903,18,Discharge,O
103903,18,Instructions,O
103903,18,:,O
103903,18,none,O
103903,18,Followup,O
103903,18,Instructions,O
103903,18,:,O
103903,18,none,O
103903,18,Completed,O
103903,18,by,O
103903,18,:,O
103903,18,[,O
103903,18,*,O
103903,18,*,O
103903,18,2163-6-15,O
103903,18,*,O
103903,18,*,O
103903,18,],O
